Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02372773 · ClinicalTrials.gov registry record
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
A clinical trial of Familial Frontotemporal Dementia, sponsored by Mayo Clinic.
- Completed
- Registry status
- 398
- Enrollment target
- 8
- Study locations
NCT02372773: Completed study of Familial Frontotemporal Dementia, sponsored by Mayo Clinic.
NCT02372773 is a study of Familial Frontotemporal Dementia that has completed, run by Mayo Clinic. The registered enrollment target is 398 participants. The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02372773, a study of Familial Frontotemporal Dementia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 398 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is being done to learn more about normal thinking and behavior, mild thinking and behavior problems, Frontotemporal Dementia and other forms of dementia in families in which one or more relatives have a mutation associated with Frontotemporal Dementia.
Primary Outcome
neuropsychological, clinical/behavioral, neuroimaging measures
Conditions Studied
Study Locations (8)
California
- University of California, San Francisco, Memory and Aging Center, Department of Neurology - San Francisco
Florida
- Mayo Clinic Florida - Jacksonville
Massachusetts
- Harvard University - Charlestown
Minnesota
- Mayo Clinic - Rochester
Missouri
- Washington University - St Louis
New York
- Columbia University - New York
Pennsylvania
- Univerisity of Pennsylvania - Philadelphia
British Columbia
- University of British Columbia - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-06-30 |
What the finished NCT02372773 record still lists
NCT02372773 is an observational study that tracks outcomes without assigning an intervention. The registered 398 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Familial Frontotemporal Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT02372773 lists 8 locations in 8 states (California, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02372773 about?
NCT02372773 is a clinical study titled "Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects". This study is being done to learn more about normal thinking and behavior, mild thinking and behavior problems, Frontotemporal Dementia and other forms of dementia in families in which one or more relatives have a mutation associated with Frontotemporal Dementia.
What is the current status of trial NCT02372773?
This trial is currently completed. The enrollment target is 398 participants. The study started on 2015-04. Estimated completion is 2020-06-30.
What conditions does trial NCT02372773 study?
This clinical trial studies the following conditions: Familial Frontotemporal Dementia.
Who is sponsoring clinical trial NCT02372773?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02372773 being conducted?
This trial has 8 study locations across California, Florida, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia